RAVI C SHAH
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- PARKER, CO
- NPI
- 1013999895
- Received
- $1,295,184 in 2,852 records, 2019 to 2025
- As principal investigator
- $3,384 of research payments to others in 1 record
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 428 | $222,003 |
| 2024 | General payment | 307 | $152,897 |
| 2023 | General payment | 361 | $164,931 |
| 2022 | General payment | 377 | $169,561 |
| 2021 | General payment | 494 | $271,169 |
| 2020 | General payment | 406 | $184,256 |
| 2019 | General payment | 479 | $130,365 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 357 | $969,339 |
| Consulting Fee | 88 | $179,384 |
| Travel and Lodging | 491 | $58,246 |
| Food and Beverage | 1,898 | $51,703 |
| Honoraria | 13 | $36,467 |
| Education | 5 | $43 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-26 | PFIZER INC. | $3,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-24 | UCB, Inc. | $29 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-23 | ABBVIE INC. | $1,750 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-22 | ABBVIE INC. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-12-22 | ABBVIE INC. | $525 | Consulting Fee | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-19 | ABBVIE INC. | $121 | Travel and Lodging | In-kind items and services | BOTOX Biological, FACIAL AESTHETICS | 2025 | |
| 2025-12-18 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-17 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-17 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-16 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-15 | ARGENX US, INC. | $29 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-12-15 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-15 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-10 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-12-10 | PFIZER INC. | $6 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-10 | PFIZER INC. | $2 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-09 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-08 | ABBVIE INC. | $140 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-08 | Ipsen Biopharmaceuticals, Inc | $29 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-12-06 | Ipsen Biopharmaceuticals, Inc | $64 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-12-06 | ABBVIE INC. | $57 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-12-05 | Axsome Therapeutics, Inc. | $130 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-05 | Lundbeck LLC | $50 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-12-05 | Axsome Therapeutics, Inc. | $31 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-05 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-05 | Ipsen Biopharmaceuticals, Inc | $6 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-12-04 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-04 | ABBVIE INC. | $16 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-03 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-12-03 | ABBVIE INC. | $41 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-12-02 | ABBVIE INC. | $8,925 | Consulting Fee | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | ABBVIE INC. | $1,516 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-02 | ABBVIE INC. | $350 | Consulting Fee | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | ABBVIE INC. | $50 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-24 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-20 | ABBVIE INC. | $350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-19 | Axsome Therapeutics, Inc. | $1,725 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-11-19 | ABBVIE INC. | $350 | Consulting Fee | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | ABBVIE INC. | $350 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-19 | ABBVIE INC. | $350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $9 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $9 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-11-19 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-18 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-18 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-18 | PFIZER INC. | $610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-11-18 | Axsome Therapeutics, Inc. | $81 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-11-18 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-17 | Neurocrine BioSciences, Inc. | $33 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-15 | ABBVIE INC. | $59 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-15 | ABBVIE INC. | $59 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-15 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-15 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-14 | ABBVIE INC. | $334 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-14 | ABBVIE INC. | $142 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-14 | ABBVIE INC. | $63 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-14 | ABBVIE INC. | $54 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-14 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-13 | PFIZER INC. | $112 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-11 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-06 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-05 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-04 | PFIZER INC. | $1,800 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-04 | Neurelis, Inc. | $21 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-10-30 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-29 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $11 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $5 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $4,888 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $402 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $292 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $122 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $70 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $39 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $19 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $17 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $12 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $11 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-23 | Axsome Therapeutics, Inc. | $9 | Food and Beverage | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-22 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-22 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-21 | ARGENX US, INC. | $29 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-20 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-10-15 | Lundbeck LLC | $1,185 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-10-15 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | PFIZER INC. | $1,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-14 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-13 | Neurocrine BioSciences, Inc. | $31 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $4,888 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $716 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $255 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $119 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $70 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $39 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $29 | Food and Beverage | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-09 | Axsome Therapeutics, Inc. | $11 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-10-07 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-01 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-01 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | Tanabe Pharma America, Inc. | $20 | Food and Beverage | In-kind items and services | Radicava Drug, Not Applicable | 2025 | |
| 2025-09-30 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-29 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-25 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-24 | CSL Behring | $17 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-09-23 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-19 | SK Life Science, Inc. | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Neurelis, Inc. | $21 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-09-11 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $57 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | ABBVIE INC. | $5 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-10 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-09-10 | Lundbeck LLC | $4 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-09-09 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-08 | Ipsen Biopharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-09-08 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-04 | ABBVIE INC. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-03 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-02 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-02 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-28 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-26 | EMD Serono, Inc. | $19 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-08-26 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-22 | ABBVIE INC. | $81 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-08-22 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-08-22 | ABBVIE INC. | $23 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-22 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-22 | ABBVIE INC. | $15 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-22 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-21 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | Neurelis, Inc. | $20 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-08-20 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-19 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-19 | ABBVIE INC. | $22 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-19 | ABBVIE INC. | $5 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-18 | Alexion Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-08-18 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ANI Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-08-13 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | Axsome Therapeutics, Inc. | $96 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-08-12 | Grifols USA, LLC | $21 | Food and Beverage | In-kind items and services | Gamunex-C Biological, Immunology and Neurology | 2025 | |
| 2025-08-12 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-11 | Neurocrine BioSciences, Inc. | $31 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-08-08 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-08-07 | ABBVIE INC. | $52 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-07 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-07 | ABBVIE INC. | $5 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $109 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $72 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $2 | Travel and Lodging | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | ABBVIE INC. | $65 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-05 | ABBVIE INC. | $5 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-08-04 | Lilly USA, LLC | $27 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-07-31 | Axsome Therapeutics, Inc. | $1,725 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-31 | Axsome Therapeutics, Inc. | $22 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-31 | Axsome Therapeutics, Inc. | $5 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $3,738 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $107 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $83 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $2 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-29 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-29 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-07-28 | PFIZER INC. | $2,250 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-21 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-07-17 | Axsome Therapeutics, Inc. | $9,775 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-07-17 | ABBVIE INC. | $2,100 | Consulting Fee | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | ABBVIE INC. | $700 | Consulting Fee | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | ABBVIE INC. | $525 | Consulting Fee | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | ABBVIE INC. | $700 | Consulting Fee | Cash or cash equivalent | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-07-16 | SK Life Science, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-15 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-14 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-14 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-09 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-08 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-08 | Life Molecular Imaging Ltd | $16 | Food and Beverage | Cash or cash equivalent | NEURACEQ Drug, Diagnostic Tracer | 2025 | |
| 2025-07-07 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-07 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WaveWriter Alpha Prime 16 Device, WaveWriter Alpha_NMD | 2025 | |
| 2025-07-07 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 |
The latest 200 records of 2,852.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2019-06-13 | Novartis Pharmaceuticals Corporation | NEUROLOGY OF THE ROCKIES LLC | $3,384 | LONG TERM PROSPECTIVE MULTINATIONAL PARALLEL COHORT STUDY MONITORING SAFETY IN PATIENTS WITH MULTIPLE SCLEROSIS NEWLY ST | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Parker, CO, county Douglas County, CO, state Colorado; placed by its city name.
| Measure | Place (city or town) Parker, CO | County Douglas County, CO | State Colorado |
|---|---|---|---|
| Population B01003 | 61,783 | 377,150 | 5,862,189 |
| Population, 2020 census P1 | 58,512 | 357,978 | 5,773,714 |
| Median age B01002 | 36.2 | 39.6 | 37.7 |
| Under 18 B01001 | 25.7% | 23.4% | 21.0% |
| 65 and over B01001 | 10.7% | 13.9% | 15.6% |
| Households B11001 | 21,789 | 139,960 | 2,374,218 |
| Foreign born B05002 | 10.7% | 8.4% | 9.8% |
| Median household income B19013 | $133,369 | $149,594 | $95,470 |
| Median family income B19113 | $153,576 | $171,592 | $119,139 |
| Per capita income B19301 | $56,841 | $69,608 | $52,636 |
| Poverty rate B17001 | 4.4% | 3.8% | 9.4% |
| Unemployment rate B23025 | 3.0% | 3.6% | 4.6% |
| Civilian labor force B23025 | 35,926 | 215,509 | 3,235,476 |
| Mean commute (minutes) B08013 | 26.1 | 27.1 | 25.2 |
| Bachelor's degree or higher B15003 | 56.0% | 62.0% | 45.7% |
| Housing units B25001 | 22,397 | 144,432 | 2,589,053 |
| Owner-occupied B25003 | 71.8% | 77.4% | 66.2% |
| Renters B25003 | 28.2% | 22.6% | 33.8% |
| Median home value B25077 | $646,300 | $713,600 | $539,400 |
| Median gross rent B25064 | $2,096 | $2,193 | $1,761 |
| White, not Hispanic B03002 | 71.6% | 77.0% | 64.8% |
| Black B03002 | 1.7% | 1.3% | 3.8% |
| Hispanic or Latino B03002 | 12.9% | 10.2% | 22.5% |
| Asian B03002 | 7.6% | 5.8% | 3.2% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.4% |
Economy now FRED unemployment 4.1% in Sep 2026 (3.8% a year earlier); per capita personal income $86,342 in 2025, up 34% in five years (+7.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Parker, CO.
Comments